Why UiPath Stock Is Soaring in After-Hours Trading

UiPath reported Q3 FY2026 revenue of $411.0 million, up 16% year-over-year and above the $392.9 million consensus, and posted adjusted EPS of $0.16 versus $0.15 expected (a 45% y/y increase). Annualized renewal run rate rose 11% to $1.782 billion and management said the company achieved its first GAAP-profitable quarter; it guided Q4 revenue to $462–467 million. Shares jumped roughly 9% in after-hours trading and the stock currently trades at 17.6x operating cash flow versus a five-year average of 39.1x, highlighting improved fundamentals alongside a discounted valuation.

Analysis

Market structure: UiPath’s beat (Q3 revenue $411M, +16% YoY; annualized renewal run rate $1.782B, +11% YoY) strengthens RPA vendors and enterprise automation sellers; direct beneficiaries include PATH, systems integrators and cloud partners increasing implementation demand. Investors rotating from frothy AI hardware names into cheaper software plays can reprice PATH upward — current 17.6x operating cash flow versus 5‑yr avg 39.1x implies a potential 50–100% re‑rating if growth sustains. Cross-asset: a sustained software rerating would modestly steepen credit spreads for high-yield tech names and lift equity vols in AI mega-caps while USD moves are likely immaterial unless enterprise spending signals broader growth revision.

Risk assessment: Tail risks include a sharp enterprise IT budget pullback, one-off accounting improving GAAP profitability (not repeatable), or regulatory/data‑privacy constraints on automation (low probability, high impact). Time horizons: days — tradeable volatility around after‑hours move; weeks/months — Q4 guide ($462–$467M) is the next binary; quarters/years — sustained ARR growth >10% YoY needed to justify a re‑rating. Hidden dependencies: ARR growth is lumpy and concentrated with large deals; customer churn or lower deal size would reverse sentiment quickly. Catalysts: Q4 execution, large public-sector wins, partner integrations, and next two GAAP quarters of profitability.

Trade implications: Direct play — establish a 2–3% long equity position in PATH sized to portfolio risk, financed by selling expensive options or using call spreads to cap cost; target re‑rate to 30x OCF (~+70% upside) if ARR growth remains >10% for next 4 quarters. Pair trade — long PATH vs short an overvalued AI growth ETF (e.g., small $1–1.5% hedge via short ARKK exposure) to capture relative rerating. Options — prefer 4–6 month call spreads (buy Sep/Jan 6‑month $15/$22) or sell cash‑secured $12 puts for yield; use a 15% stop if revenue guidance is missed by >2%.

Contrarian angles: Consensus overlooks sustainability of GAAP profitability — one quarter doesn’t confirm margin expansion; if OCF reacceleration stalls (ARR growth <5% YoY), the current move is overdone and reversion of 20–40% is plausible. Historical parallels: SaaS re‑ratings (e.g., earlier Snowflake upswing) required 2–3 quarters of consistent beats; treat PATH similarly. Unintended consequence: rapid cost cutting to sustain GAAP profits could harm product R&D and long‑term competitive moat, so require 2 consecutive profitable quarters plus stable renewal metrics before adding size beyond 3%.

Key Decisions for Investors

• Establish a tactical long position in PATH sized 2–3% of portfolio via equity purchase near market or staggered limit buys at $13–$15, with target price +50–75% (implied re‑rating to ~30x OCF) and hard stop if Q4 revenue < $453M (2% below low guidance).
• Implement a low‑cost upside via 4–6 month bull call spread: buy PATH 6‑month $15 call and sell $22 call (ratio 1:1) to cap cost and target ~+40–60% return if market re‑rates; allocate no more than 0.5–1% portfolio risk to options premium.
• Write cash‑secured PATH $12 puts (3–4 month expiries) at attractive implied yield if comfortable owning below current levels; if assigned, average cost basis target ~$12–13 representing ~20–25% downside cushion.
• Pair trade: go long PATH 2% vs short ARKK (or similar AI/growth ETF) 1–1.5% as hedge against broad AI multiple compression; rebalance after Q4 earnings or if PATH ARR growth decelerates below +5% YoY.
• Trigger-based monitoring: increase size to 4–5% only after two consecutive GAAP profitable quarters and ARR growth >10% YoY; reduce/exit if either metric falls below thresholds (profitability reverses or ARR <5% YoY).